Trial NCT00468910

Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer

This randomized phase II trial is studying how well aspirin works in preventing colorectal
cancer in patients at increased risk of colorectal cancer. Chemoprevention is the use of
certain drugs to keep cancer from forming. The use of aspirin may prevent colorectal cancer.

Intervention

acetylsalicylic acid, placebo, laboratory biomarker analysis

Condition

Colon Cancer, Precancerous Condition, Rectal Cancer

Investigators

See list of participating sites